Xizang Haisco Pharmaceutical Group Co LtdHaisco provides a 165 million yuan loan to its controlling subsidiary Haisijieyin to supplement working capital and support business development.

Haisco announced on October 11 that it plans to provide financial assistance in the form of a loan using its own funds to its controlling subsidiary Haisijieyin, with the amount not exceeding 165 million yuan. Haisijieyin's minority shareholder Hailikesi will provide financial assistance under the same conditions in proportion to its capital contribution, with the amount not exceeding 18.97 million yuan. The annualized interest rate of the loan is 3.05 percent, and the loan facility is valid for five years. Haisijieyin needs to draw down the funds in installments according to its capital usage plan, and any single loan must be fully repaid by the end of the five-year period. This financial assistance is intended to promote the business development of Haisijieyin and supplement its working capital, and will not affect the company's normal business operations. In the first half of 2026, Haisco achieved revenue of 3.096 billion yuan and net profit attributable to the parent company of 851 million yuan.
Xizang Haisco Pharmaceutical Group Co LtdHaisco provides a 165 million yuan loan to its controlling subsidiary Haisijieyin to supplement working capital and support business development.
Haisijieyin receives up to 165 million yuan in financial assistance from parent Haisco, supplementing its working capital.